A database of genetic information of more than 270 cancer models, encompassing 25 different childhood cancers, has just been made publicly available. Children’s Cancer Institute contributed 90 leukaemia models to this global effort.
The 2018 Live for Lily Butterfly Ball was held on 16 June in Melbourne’s Palladium at Crown. It was a fantastic evening and a huge success, raising much-needed funds to support our research.
We’ve just launched our Strategic Plan for 2018–2022. The culmination of months of consultation and thought, it provides a road map for achieving our vision as quickly as possible.
NSW Health Minister Brad Hazzard has announced a $1 million funding boost for the Zero Childhood Cancer program. The money will support an immunotherapy trial for children with brain cancer.
How does the future look for young Australians with cancer? According to a recent article by Cancer Institute NSW, it’s looking brighter, and our work’s playing a vital role.
It’s six months since the Zero Childhood Cancer personalised medicine national clinical trial began. We'd like to share some of our progress with you.
Without treatment, Lexie had two weeks to live. Overnight she became ‘the kid with cancer’.
We’ve already started opening our presents. Christmas has come early as new technologies take their place in our labs, promising to speed up childhood cancer research.
Biljana Dumevska is the Laboratory Operations Coordinator in our Personalised Medicine team. With the national launch of the Zero Childhood Cancer personalised medicine clinical trial in September, there’s plenty to coordinate.
Brain cancers are the leading disease-related cause of death in Australian children. In this article, first published in The Conversation, A/Prof David Ziegler explains what we can learn from improving childhood leukaemia survival.